Total Funding
48
64
Total FundingVenture - Series Unknown raised
Growth Score
-3 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
52201
Convelo Therapeutics specializes in developing medicines to regenerate myelin around nerve cells and restore function
- Paul Tesar: Co-Founder
- Drew Adams: Co-Founder and VP of Discovery
About the Company
Convelo Therapeutics specializes in developing medicines to regenerate myelin around nerve cells and restore function. The company's scientists have developed an innovative platform to identify novel candidate treatments capable of directly stimulating stem cells in the central nervous system to form new myelin.
